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Lack  of  quantitative  relation  between  agglutinin  titer  and  protective  or 
bactericidal properties  of  antisera  has  been observed for some  time by  nu- 
merous  workers  studying  immunity  to  bacterial  infections  in  experimental 
animals  (1-8  and  unpublished  data  from  this  laboratory).  Other  workers 
(9-11) have found a  good correlation between agglutinin titer and protective 
properties of antisera. In most of the studies quoted above, the antibody pre- 
sumably involved in protective immunity was directed against a  surface anti- 
gen  (e.g.,  O-antibody) and,  despite the lack of quantitative correlation, pro- 
tection  was  usually  associated  with  the  presence  of  agglutinins.  In  some 
instances however, sera collected a  few days after immunization  (6)  or anti- 
sera prepared with heterologous antigen (2)  were protective, even though no 
agglutinating  antibody  could  be  demonstrated.  From  these  and  other  con- 
siderations  to  be  discussed  below,  it  appears  that  the  agglutinin  titer  may 
misrepresent  the  concentration  of  antibody  to  surface  antigens  in  a  given 
serum  qualitatively  as  well as  quantitatively;  i.e.,  some  antibodies,  though 
directed  against  surface  antigens,  may  not  participate  in  agglutination  at 
all, while others may affect the agglutinin titer to varying degrees. Conversely, 
some antibodies may be more protective than others. A necessary preliminary 
to the in vitro characterization and estimation of protective antibody is there- 
fore the measurement and characterization of the antibody content of a given 
serum. 
As pointed out recently by Talmage and Freter (12), most methods of antibody 
assay utilize 2-stage  reactions,  such  as agglutination,  precipitation, hemolysis,  etc., 
as indicators  of  the primary antigen-antibody union.  However, the intensity of a 
second stage reaction is not necessarily proportional to the number of antibody mole- 
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cules absorbed by the antigen, and many reports may be cited of non-agglutinating 
(13, 14) and non-precipitating antibodies  (15, 16), and of antibodies with different 
hemolytic efficiency (17). Another frequently used method for estimating total anti- 
body, i.e., the analysis of antibody nitrogen absorbed, involves  a  considerable  error 
owing to the relatively large amount of antigen nitrogen, especially  when the possi- 
bility of lysis of the bacteria cannot definitely be excluded. Moreover, it is known that 
antibodies of different specificities may have different molecular weights.  In at least 
one case (17), antibodies of different efficiency in the second stage reaction (hemolysis) 
were shown to be of different molecular size, even though their specificities appeared 
to be identical or closely related. For these reasons,  the amount of antibody nitrogen 
absorbed may not always provide a reliable measure of the relative number of antibody 
molecules that have combined with the antigen. 
Recently, Talmage and Freter (12)  developed a  test for the study of sheep 
red  blood  cell antibodies  which  appears  to  be free from most of the  short- 
comings discussed above. The test measures the absorption of an 1181 labelled 
antibody preparation by the antigen.  If an unknown unlabelled  antiserum is 
added  to  standard  amounts  of  these  reagents,  the  unknown  antibody  will 
compete with the labelled antibody for the antigenic sites available, resulting 
in  a  decreased  absorption  of radioactivity  by  the  antigen.  That  amount  of 
unknown serum which, under the conditions of this test, reduced the amount 
of radioactivity absorbed by 50 per cent was designated by these authors as 
one "combining unit." The "combining capacity" of the unknown serum was 
expressed in terms of combining units per milliliter. The reduction or blocking 
of the  uptake  of radioactivity  appeared  to  be a  function  of  the  number  of 
antigenic  sites  occupied  by  antibody  from  the  unknown  serum,  essentially 
independent  of second stage reactions and independent  of the molecular size 
of the unknown antibody. 
In the studies  to be reported here,  this test, referred to hereafter as "Tal- 
mage test," has been adapted for the study of antisera to  Vibrio cholerae  and 
Shigella flexneri,  and  the  results  obtained have been compared with  the  ag- 
glutinin  titration.  The  investigations were begun prior to  the  publication  of 
Talmage and Freter's studies  (12),  and the present writer is greatly indebted 
to these authors for their kindness in discussing with him work they had then 
in progress. 
Materials and Methods 
Antigens.--Antigens  were prepared from a streptomycin-resistant strain of Vibrio chderae 
and of Shigdla flexneri type 2a, which have been described previously (18). The data given 
below refer to  Vibrio cholerae antigens and  antisera, and  corresponding data for Shigdla 
flexneri, if different, are shown  in parenthesis. The organisms were grown  for 18 hours at 37°C. 
on veal infusion agar (Difco) containing 1 mg./ml, streptomycin sulfate, suspended in 0.85 per 
cent saline, boiled in a round bottom flask over low heat for 2 hours (heated for 2 hours at 
100°C. in the flowing steam), and washed 3 times. The suspensions were then adjusted with a 
Klett-Summerson colorimeter to a standard density, corresponding to about 20 mg./ml, dry ROL~  F~TER  625 
weight of bacterial substance. These preparations will be referred to as standard 100-antigens. 
Suspensions from similar cultures, heated for 15 minutes at 56°C., washed and standardized 
to the same density as above, will be designated standard 56-antigens. Antigens were stored 
at 4°C. without preservative; batches older than 3 weeks were discarded. On the day of use, a 
suitable dilution of standard antigen was prepared and washed again once with saline. All 
data given below in any one figure or table were derived from tests employing the same batch 
of antigen. 
Antisera.--Female New Zealand Red rabbits weighing 5 to 7 pounds were immunized by the 
intravenous route at 4 to 5 day intervals, starting with a dose of 0.25 mg. (0.06 rag.) standard 
antigen diluted in saline, and doubling the amount of antigen with each successive injection. 
The 7th (8th) and all following injections consisted of 12 mg. (4 rag.) antigen. Eight to 9 ml. of 
blood was taken from the ear vein before the  1st, 3rd,  5th,  etc.,  injection, the  serum was 
separated,  inactivated at 56°C.  for 45 minutes and stored without  preservative at  -20°C. 
Normal rabbit serum used for diluting, etc., was inactivated and stored in the same way. Sera 
are designated by the number of the animal from which they were taken, followed by  the 
number of antigen injections given. If necessary, the kind of antigen is indicated in parenthesis, 
e.g., serum 9-5/4(56) was taken from rabbit 9-5 after 4 injections of 56-antigen. For reasons of 
convenience, sera taken early or late in the course of immunization will be referred to here- 
after as "early" or "late" antisera. 
Standard Agglutinin Titrations.--Agglutinin  titers were determined in quadruplicate series 
of tests, using 2-fold serum dilutions and starting 2  series with a  1:100 dilution, the other 
2 with a  1 : 140 dilution. Equal volumes of standard 100-antigen in 1 : 100 dilution were added. 
The titrations were carried out by 2 individuals, each preparing 2 dilution series of a  given 
antiserum. The  tests were  read  after  overnight incubation at 37°C. i.e., when  the highest 
titer was obtained. The highest dilution at which agglutination could be detected by inspection 
with a hand lens was taken as the agglutinin titer. Readings were carried out by 2 individuals, 
one of whom was unaware of the identity of the sera. The reciprocals of agglutinin titers from 
all titrations of a given serum were averaged. Individual readings agreed closely and the error 
of the mean titers was well below 2-fold. 
Labelled Antibody Eluate.--The globulin fraction of an antiserum was precipitated with 50 
per cent saturated  ammonium sulfate, washed,  separated  by centrifugafion, and  dialyzed 
against frequent changes of 0.85 per cent saline at 4°C.  for 2  days.  Ten rag.  globulin in a 
volume of 0.5 ml. was then iodinated with 10 inc. I m  as described by Talmage, Baker, and 
Akeson (19). Ten to 60 rag. standard 100-antigen  t was added to the 10 ml. of labelled globulin 
solution thus obtained, and the mixture allowed to stand at room temperature for 30 minutes. 
The antigen was then separated by centrifugation and washed 3 times at room temperature 
with a mixture containing 6 volumes of 0.85 per cent saline, 3 volumes normal rabbit serum, 
and 1 volume of 0.15 N KI. Depending on the globulin fraction used, the antigen retained 3 to 
30 per cent of total radioactivity in the labelled globulin. The washed antigen was suspended 
in 2 ml. of the antiserum from which the original globulin fraction had been prepared and 
incubated with frequent agitation at 45°C. for 20 minutes. At this time 10 to 40 per cent of the 
labelled antibody absorbed by the antigen would elute, presumably owing to carrier exchange 
and to thermal dissociation. After centrffugation, the supernate was decanted and stored at 
4°C. without preservative. This "antibody eluate" could be used  for 2 to 6  weeks i.e.,  until 
the radioactivity had decayed below the level of exact measurement. On the day of use the 
1 The exact amount of antigen to be added depends on the total antibody content of the 
labelled globulin fraction. Use of too much antigen resulted in insufficient elution of antibody 
in the subsequent step. More study is needed to determine the exact influence of the antigen: 
antibody ratio employed at this step of the procedure on avidity and other qualities of the 
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eluate was diluted (usually 1:100) in  0.85 per cent saline containing  10 per cent normal rabbit 
serum and centrifuged to remove possible traces of bacterial contamination. 
The radioactivity of samples was counted in 13 X 100 mm. test tubes in a well-type Texaco 
Geiger counter or in a well-type scintillation counter. 
EXPERIM~,NTAL 
Before using a freshly  prepared antibody eluate,  its quality was tested  by 
studying the absorption of labelled antibody on standard antigen. 
The eluate was diluted so that a 0.5 ml. sample gave several thousand counts per minute. 
One-half ml. amounts were then distributed  into several 13 ram. test  tubes, and different 
amounts of standard antigen in a 1.1 ml. volume added. The mixtures were allowed to stand 
at room temperature  for 30 minutes. After centrifugation,  sediments and supernates were 
separated by decanting, and the radioactivity  in both fractions determined. A control tube 
containing only eluate in a 1.6 ml. volume was included to determine the fraction of supernate 
remaining in the tube after decanting (usually about 5 per cent). In order to correct for unde- 
canted supernate in tubes containing the sediment, the following formula was used for calcu- 
lating the percentage of radioactivity absorbed: 
p-  (cs) 
Per cent =  --. 100  (1) 
p+s 
in which  p  -  counts  in sediment, s =  counts  in supernate,  and c =  fraction  of unde- 
canted  supernate  in the control tube.  Fig. 1 illustrates absorption  curves  obtained  with 
different eluates. Eluates  E and L are typical examples, eluate Ve was derived from a very 
early antiserum and will be discussed later. 
As can be seen, about 80 to 90 per cent of total radioactivity was absorbed 
from a  typical eluate by an excess; i.e.,  1 ml. of undiluted standard antigen. 
Successive absorptions with  this amount of antigen usually removed another 
10 per cent of total radioactivity, indicating that  only about  10 per cent of 
all 1131 in the eluate was bound to non-antibody globulin. In the actual TaP 
mage  test  as  carried  out  here,  0.05  ml.  (1  mg.)  standard antigen was  used 
throughout because  the  absorption curves  of  most  eluates were  steepest  at 
this  antigen concentration,  indicating maximal  sensitivity to  a  decrease  in 
available antigen sites (Fig. 1). About 55  to 70 per cent of total radioactivity 
was absorbed from different eluates under these conditions. In order to obtain 
accurate assays of radioactivity, the concentration of eluate employed in the 
test had  to be increased as  the radioactivity decayed during storage.  It was 
found  that  most  eluates could be  concentrated 2-  to  8-fold  without  signifi- 
cantly decreasing  the  percentage  of  total  radioactivity absorbed  by  1  mg. 
standard antigen. 
For testing the combining capacity of unknown sera, the following  reagents were mixed in 
order: 0.5 ml. of a suitably diluted antibody eluate; varying amounts of unknown serum and 
0.85 per cent saline to a combined volume of 1.1 ml.; and 1 rag. standard antigen in 0.5 ml. 
saline (total volume 1.6 ml.). Two control tubes were included with each series of tests, con- 
taining (a) 0.5 ml. eluate plus 1.1 ml. saline, to determine the fraction of supernate that would ROLF  FRETER  627 
remain after decanting; and (b) 0.5 ml. eluate, 0.6 ml. saline plus 1 mg. standard antigen in 
0.5 ml. saline, to test the percentage of radioactivity absorbed by the antigen from eluate 
alone. The reactions reached equilibrium in 1 minute or less, but 30 minutes standing with 
occasional agitation at room temperature (24-27°C.)  was allowed routinely. The tubes were 
then centrifuged for 10 minutes at about 1200  X  gravity in a  Servall type SP/X angle cen- 
trifuge, the supernates decanted from the sedimented antigen, and the radioactivity of both 
fractions counted. The percentage of radioactivity absorbed by the antigen was calculated 
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Fro.  1.  Absorption by Vibrio 100-antigen of labelled antibody from different eluates 
according to formula (l) and plotted against the logarithm of the amount of unknown serum 
(Fig. 2). The amount of unknown serum which reduced the uptake of radioactivity by the 
antigen to one-half of that absorbed from the eluate alone (control b) was taken from this 
"blocking curve" and designated as one combining unit. 
The blocking curves of all antisera tested were s-shaped. However, only the 
straight part of the curves is shown in Fig. 2 because measurements with the 
present  technique were most accurate in  this region.  The specificity  of the 
Talmage  test was indicated by the fact that  labelled antibody from  Vibrio 
antisera was not absorbed  by ShigelIa  antigen, and  vice  versa.  Furthermore 628  AGGLUTINATING  AND  COM'RINING 0]~ ANTISERA 
normal or Shigella  antiserum had little or no effect on the absorption of radio- 
activity from Vibrio antibody eluate by Vibrio  antigen. 
Table I  gives some representative results obtained with antisera to  Vibrio 
cholerae. The eluate used in these tests was obtained from an antiserum which 
had  been prepared like  serum  9-0/8(56)  or 9-2/8(56),  and  100-antigen  was 
used in both Talmage test and agglutinin titration. Sera from rabbits  9-0,  9-2, 
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Fro. 2. Blocking curves of different Vibrio 56-antisera. Tested with a labelled antibody 
eluate prepared from 56-antiserum. (The designation 9-2/6 refers to an antiserum taken from 
rabbit 9-2 after 6 antigen injections). 
9-5,  and 9-6 were taken successively during the primary course of immuniza- 
tion  as  described  above.  Sera  6-6/A  to  6-8/A  were  obtained  from  rabbits 
which  had undergone  a  regular  course of 8  injections of  Vibrio  56-antigen, 
after which the animals were allowed to rest for 2 months. During this time 
the agglutinin titers of their sera dropped to about  1:800. The rabbits were 
then injected 4 times with 2, 6, and 12 mg.  Vibrio 56-antigen at 4-day inter- 
vals and were bled from the heart 5 days after the last injection. As can be 
seen from Table I, high agglutinin titers were obtained in the primary course 
of  immunization  after  2  to  4  antigen  injections.  These early antisera  had, 
however, a  very low combining capacity  (i.e.  very few combining  units per ROL~ FR~T~.R  629 
ml.),  and  the  ratio  a  Mean  reciprocal  agglutinin  titer 
-  --  was  consequently 
c  Combining units per ml. 
very high.  A  steadily decreasing ale ratio was regularly observed during  the 
course  of immunization  indicating  the  appearance  of antibodies  which  were 
able to combine with antigen under  the conditions  of the Talmage test,  but 
which did not affect the agglutinin titer to any comparable degree. Antibody 
formed early during the anamnestic response to antigen (sera 6-6/A to 6-8/A) 
TABLE I 
Combining Capacities and A gglutinin Titers of Different Antisera to Vibrio cholerae 
No. of antigen injections given 
Serum No. 
13 
9-0(56) 
9-2(56) 
9-5(100) 
9-6(lOO) 
6-6/A 
C* 
a~ 
a/c 
c 
a/c 
c 
a 
ale 
¢ 
tl, 
ale 
c 
ale 
2  4 
<1  2.1 
3,840  4,400 
>3,840  2,100 
<1  3.4 
3,280  7,080 
>3,280  2,082 
<1  3.0 
5,120  5,440 
>5,120  1,813 
<<I  1 
200  2,720 
--  2,720 
79  6-7/A 
14,540 
184 
* c =  combinin 
a =  mean reciprocal agglutinin 
6 
4.7 
4,640 
987 
5.6 
5,440 
971 
11 
8,640 
785 
6.3 
6,560 
1,041 
c 
a 
a/¢ 
8  10 
40  16 
9,920  3,280 
248  205 
34  22 
15,080  16,960 
444  770 
19  42 
9,780  17,280 
515  411 
7.5  15 
3,280  3,840 
438  256 
32  6-8/A 
7,200 
225 
12 
8.4 
1,800 
214 
22 
9,440 
429 
35 
18,560 
530 
18 
2,320 
129 
c 
a/~ 
capacity  (number of combining units per milliliter). 
titer. 
3.5 
1,440 
412 
30 
6,560 
219 
21 
6,080 
290 
9.4 
2,080 
221 
45 
18,555 
412 
appeared to be of the same type (low ale ratio) as that found in the late stages 
of the primary course of immunization. Results similar to those illustrated in 
Table I  were obtained when Shigella 56- and  100-antisera were tested with a 
labelled  antibody  eluate  prepared  from  100-antiserum,  using  100-antigen  in 
Talmage tests and agglutinin titrations. 
One possible criticism of the above results could be that the relatively low 
agglutinin  titers  of  late  antisera,  for which  the  Talmage  test  showed  large 
amounts  of  antibody,  might  have been  due  to  insufficient  concentration  of 
some  non-specific substance  necessary  for  agglutination  to  occur.  This  pos- 
sibility  was  ruled  out  by using  a  1:1000  dilution  of Shigella  100-antiserum 630  AGGLUTINATING  AND  COMBINING  OF  ANTISERA 
(agglutinin  titer  1:12,800)  as  diluent  in  the  agglutinin  titration  of  Vibrio 
antisera  6-6/A  and  9-6/12.  The  presence  of  this  Shigella  antiserum  which 
should  have  supplied  the  suspected  non-specific  substance  did  not  increase 
the agglutinin titer of the cholera antisera. 
The following experiments  were carried  out to test  the amount of  antigen 
needed for absorption of antibody from early and late  antisera. 
Vibrio 100-antisera were diluted  in normal  rabbit  serum  to give approximately  equal 
agglutinin titers. Varying amounts of homologous 100-antigen in 1 ml. saline were added to 
equal volumes of these sera aud the mixtures allowed to stand with occasional agitation  at 
room temperature  for 30 minutes. The antigen was then separated by centrifugation and the 
aggiutinin titers of the supernates determined by standard  agglutinin tests. 
TABLE II 
Mean Reciprocal Agglutinin  Titers of Vibrio lO0-Antisera Absorbed with Different Amounts of 
Homologous Antigen 
Serum No. 
Standard antigen used for absorption, rag. 
0  1.0  1.7  2.9 
11-8/4 (early)  384  68  14.0  10.0 
9-5/13 (late).  307  192  [  128  48 
5.0 
14.0 
18.0 
Table  II  illustrates  representative  results  obtained  with  early  and  late 
antisera.  As can be seen, late antiserum required more antigen for absorption 
than  early  antiserum  of  similar  original  agglutinin  titer.  This  result  might 
indicate  (a) that late antiserum combines poorly with antigen,  or (b)  that late 
antiserum  contains relatively more antibody than  early antiserum.  Since the 
Talmage test indicated a relatively higher combining capacity for late  antisera, 
the second interpretation  appears to be more likely. 
In the present  studies Talmage tests were conducted at antigen  concentra- 
tion  and  temperature  different  from those  of standard  agglutinin  titrations. 
In order  to study agglutination  under conditions  comparable  to  those  of the 
Talmage test,  the following experiments  were carried out. 
Antisera were diluted serially in 1 ml. amounts of saline and mixed with 1 rag. standard 
100-antigen in 0.5 ml. saline. The tubes were then allowed to stand  at room temperature, 
avoiding agitation as much as possible. At high serum concentrations the end-point was taken 
as the time at which agglutination  could be detected by inspection with the unaided eye. At 
lower serum concentrations, this end-point was determined by using a hand lens. 
Table  III  illustrates  representative  results  obtained  with  early  and  late 
Shigella antisera.  Serum 3/4(100),  an early serum taken after 4 antigen injec- 
tions, had an agglutinin  titer of 1:12,800 in the standard  agglutinin  test  and 
a  combining  capacity  of  2.5  units  per  ml.  in  the  Talmage  test,  both  tests 
carried  out  with  100-antigen.  The  corresponding  data  for  serum  3/13  are gOLF FP,_EX~R  631 
a  =  1600 and c =  25 units per ml.  Under the experimental conditions used, 
serum 3/4 had a higher  agglutinin titer than serum 3/13  (Table III), just as 
in the standard  agglutinin  titration.  However, serum 3/13 at higher  concen- 
trations agglutinated the antigen much faster than serum 3/4. Similar  differ- 
ences in the speed of agglutination  were regularly found with early and late 
antisera  to Shigella flexneri  and  Vibrio  cholerae. These results  indicate  that 
the differences  in ale  ratios  of early and  late  antisera  (Table I)  cannot  be 
explained  simply  by assuming  varying  amounts  of  non-agglutinating  "uni- 
valent" antibody. Boyd (20) in studies on blood typing found different speeds 
of agglutination in different antisera and stated that the agglutinin titer "does 
not tell the whole story." The present results appear to confirm  this conclu- 
sion. 
TABLE  III 
Speed of Agglutination of Shigdla lO0-Antigen by Early (3/4) and Late (3/13) lO0-Antisera 
SertunNo. 
Reciprocal of serum dilution 
2  4  8  16  32  64  128  256  512  1024  2048  4096 
]  (90")*  [ (90")  [ (4')  ] 60"$ [ 60" [2'  [4'  [4'  [ 20'  [47'  [ 180'  [  § 
I (15")  I 
3/4 
3/13 
* Figures in parenthesis indicate time for agglutination to become visible to the unaided 
eye. 
Figures without parenthesis indicate time for agglutination to become visible on inspec 
tion with a  hand lens. 
§ No agglutination within 24 hours. 
DISCUSSION 
Talmage, Freter, and Taliaferro (17) in their studies on hemolysins found a 
steadily  decreasing  ratio  of hemolysin  units  to  combining  units  during  the 
course of immunization and explained this by the appearance of an antibody 
of low "hemolytic efficiency."  Analogously, one might also suspect the occur- 
rence of antibodies of greater or lesser "agglutinating efficiency."  The present 
finding  that late antisera  appeared to contain relatively more antibody than 
early antisera  of similar  agglutinin  titer  (Tables I  and II) may then  be ac- 
counted for by assuming higher proportions of antibody with low agglutinating 
efficiency in late antisera. 
The factor or factors responsible for agglutinating efficiency are,  at present, 
still obscure. Agglutinating  efficiency may be associated with  the specificity 
of the antibody; i.e., some surface antigens and their corresponding antibodies 
may contribute little  or nothing  towards agglutination.  The  present results 
would then indicate that the majority of antibodies in late antisera have such 
a  specificity.  However,  the  discrepancies  in  the  speed  of  agglutination  ob- 
served with early and late sera (Table HI) appear to indicate that antibodies 532  AGGLUTINATING  AND  COMBINING  O~'  ANTIS:ERA 
of  seemingly low  agglutinating  efficiency are  extremely  active  in  bringing 
about agglutination at high serum concentrations, a finding which can hardly 
be  explained  on  the  basis  of  specificity alone.  Consequently, antibodies  in 
early and late sera must differ in still other characteristics, and further studies 
are planned to investigate the nature of these differences. 
It may also be noted that the present results may have some bearing on a 
widely held immunological concept; namely, that the anamnestic response to 
particulate antigen is much less pronounced in comparison to that obtained 
with soluble antigens (21).  As can be seen from Table I, sera 6-6/A to 6-8/A 
had agglutinin titers which, in the average, were only 2.7  times higher than 
those of sera drawn after an equal number (4)  of antigen injections given in 
the  primary  course  of  immunization.  In  contrast,  the  average  combining 
capacities of the same groups of sera differed by a factor of 22. The secondary 
response,  as judged by the rise in agglutinin titers, was thus indeed a  poor 
one, not strikingly different from the primary response. However, the rise in 
combining capacities indicated a much better anamnestic response. The qual- 
ity of the anamnestic response to particulate antigens may thus, at least in 
part, depend on the type of antibody, or the antibody characteristics, which 
one chooses to measure. 
In general, the present experimental results indicate that large amounts of 
antibody may combine with the surface antigens of a  bacterial cell  without 
significantly affecting the  agglutinin  titer.  Unlike  most  of  the  well  known 
"blocking" or "univalent" antibodies, this type of antibody reached its highest 
concentration in late antisera. Furthermore, the proportion of antibodies with 
high and low agglutinating efficiency appeared to vary to such an extent that 
the agglutinin titer could not be used to estimate the relative concentrations 
of antibodies to surface antigens in different sera. It is thus not surprising to 
find discrepancies between agglutinin titer and other properties  of antisera, 
such as the protective power referred to earlier, even in such cases as those in 
which the antigens involved in protective immunity are presumably located 
on the bacterial surface. Some degree of correlation may, however, be expected 
in comparisons of antibodies with similar agglutinating efficiency, as may be 
found in  sera  drawn at  the  same  time during  the  course  of immunization. 
This assumption is supported by  the data in Table I  which show that the 
ale ratios of sera taken from different animals at the same stage of immuniza- 
tion agreed more closely than those of sera taken at different times from the 
same animal. It may also be noted in this connection that many investigators 
who found a  good correlation between agglutinin titer and protective power 
were studying antisera drawn after a  constant schedule of antigen injections 
(10,  11),  while most workers who found discrepancies analyzed sera  of less 
uniform history. It is  thus possible  that some of the discrepancies between I~0LF FRETER  633 
in vivo protective properties and in vitro behavior of antisera may be attribut- 
able to inadequacies of in vitro measurements, rather than to the complexities 
of host-parasite-antibody relationships. Further studies are planned to investi- 
gate the factor or factors which may account for the different characteristics 
of early and late sera, and to study the influence of these factors on the pro- 
tective properties of early and late sera. 
SUMMARY 
Studies of the relative combining capacities of different antisera to  Vibrio 
cholerae and Shigella flexneri were carried out using the Talmage test. In this 
test  the  absorption  of  an  I m  labelled  antibody preparation  by  antigen  is 
blocked by the addition of unlabelled unknown serum. 
Sera from rabbits in the early stages of immunization ("early antisera") had 
a  high agglutinin titer, but low combining capacity. Sera from hyperimmune 
rabbits ("late antisera") had higher combining capacities than early antisera, 
but similar or lower agglutinin titers. More antigen was needed to absorb the 
agglutinins from late  antisera  than from early ones of the  same  agglutinin 
titer,  indicating  that  late  antisera  contained  relatively more  antibody.  At 
high concentrations, sera from hyperimmune rabbits agglutinated the homolo- 
gous  antigen more  rapidly  than did  early antisera,  even  though  early sera 
had similar or higher agglutinin titers.  Sera drawn after the anamnestic re- 
sponse to bacterial antigen had the characteristics of late sera; i.e., their com- 
bining capacities were high. 
The possible significance of these findings for the in vitro estimation of pro- 
tective antibody is discussed. 
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